4.5 Article

Henoch-Schonlein Purpura in Northern Spain Clinical Spectrum of the Disease in 417 Patients From a Single Center

Journal

MEDICINE
Volume 93, Issue 2, Pages 106-113

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MD.0000000000000019

Keywords

ANCAs = antineutrophil cytoplasmic antibodies; HIV = human immunodeficiency virus; ANA = antinuclear antibodies; IQR = interquartile range; SD = standard deviation; URTI = upper respiratory tract infection; HSP = Henoch-Schonlein purpura; ACR = American College of Rheumatology; ESR = erythrocyte sedimentation rate; RF = rheumatoid factor

Funding

  1. Fondo de Investigaciones Sanitarias (Spain) [PI12/00193]
  2. Instituto de Salud Carlos III (ISCIII) (Spain) [RD08/0075, RD12/0009/0013]

Ask authors/readers for more resources

The severity of clinical features and the outcomes in previous series of patients reported with Henoch-Schonlein purpura (HSP) vary greatly, probably due to selection bias. To establish the actual clinical spectrum of HSP in all age groups using an unselected and wide series of patients diagnosed at a single center, we performed a retrospective review of 417 patients classified as having HSP according to the criteria proposed by Michel et al. Of 417 patients, 240 were male and 177 female, with a median age at the time of disease diagnosis of 7.5 years (interquartile range [IQR], 5.3-20.1 yr). Three-quarters of the patients were children or young people aged 20 years or younger (n = 315), and one-quarter were adults (n = 102). The most frequent precipitating events were a previous infection (38%), usually an upper respiratory tract infection, and/or drug intake (18.5%) shortly before the onset of the vasculitis. At disease onset the most common manifestations were skin lesions (55.9%), nephropathy (24%), gastrointestinal involvement (13.7%), joint symptoms (9.1%), and fever (6.2%). Cutaneous involvement occurring in all patients, mainly purpuric skin lesion, was the most common manifestation when the vasculitis was fully established, followed by gastrointestinal (64.5%), joint (63.1%), and renal involvement (41.2%). The main laboratory findings were leukocytosis (36.7%), anemia (8.9%), and increased serum IgA levels (31.7%). The most frequent therapies used were corticosteroids (35%), nonsteroidal antiinflammatory drugs (14%), and cytotoxic agents (5%). After a median follow-up of 12 months (IQR, 2-38 mo), complete recovery was observed in most cases (n = 346; 83.2%), while persistent, usually mild, nephropathy was observed in only 32 (7.7%) cases. Relapses were observed in almost a third of patients (n = 133; 31.9%). In conclusion, although HSP is a typical vasculitis affecting children and young people, it is not uncommon in adults. The prognosis is favorable in most cases, depending largely on renal involvement.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available